In the latest edition of the
EAHP EU Monitor, which informs us on EU matters that may impact our profession, there is the following report concerning the
EWTD.
"On 7 November 2006, the
Employment, Social Policy, Health and Consumer Affairs Council meeting under the
Finnish Presidency initiative failed to reach an agreement on modifying the
European Working Time Directive (EWTD). The Finns had proposed a compromise that did not meet the demands of
the “anti opt-out” Member State representatives, who were requesting a set end date for the opt-out option. The Finnish proposal had been to “phase out” this option.
As the text remains unchanged,
the EWTD provisions are still as follows:
* No more than 48 hours work per week (averaged over a 17-week reference period)
* 11 hours continuous rest in 24 hours
* 24 hours continuous rest in 7 days (or 48 hrs in 14 days)
* 20 minute break in work periods of over 6 hours
* 4 weeks annual leave
* Provisions for night workers
* Citizens of European Member States may ignore the above upon signing a derogation (“opt-out”)
This leaves hospital pharmacists with the problem of on-call time performed in the hospital, to be counted as part of their maximum 48 hours working time a week, whether the person does actually carry out some activities whilst on-call or does not (the European Court of Justice's rulings: SIMAP and Jaeger cases, held that
on-call duty performed by health professionals and other workers, when they are required to be physically present at their places of work, must be regarded as working time)."
SourceYou can find the whole article
here:
http://www.eahp.eu/asp/monitor_news_detail.asp?ID=15&m=11
The indicator shows the trends of erythromycin or penicillin resistance among invasive Streptococcus pneumoniae, the single most important cause of infections of the lower respiratory tract (such as pneumonia) in adults and children.
